Related Experiment Video
Updated: Dec 6, 2025
08:07
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
7.5K
The potential roles of exosomal noncoding RNAs in osteosarcoma
Shenglong Li1,2, Xiaohong Wang2,3
1Department of Bone and Soft Tissue Tumor Surgery, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, Liaoning, China.
Journal of Cellular Physiology
|October 12, 2020
Summary
Exosomes (Exos) show promise as sensitive, noninvasive biomarkers for osteosarcoma (OS) diagnosis. This review explores exosomal noncoding RNAs
Area of Science:
- Oncology
- Biochemistry
- Molecular Biology
Background:
- Osteosarcoma (OS) diagnosis is challenging due to low sensitivity and specificity of current tumor markers.
- Exosomes (Exos), nanoscale vesicles involved in cell-to-cell communication, are released by cells and transport biomolecules.
- Tumor-derived exosomes play critical roles in the tumor microenvironment, promoting cancer progression, angiogenesis, and metastasis.
Purpose of the Study:
- To review the roles of exosomal noncoding RNAs in osteosarcoma (OS) progression.
- To explore the potential of exosomal noncoding RNAs as novel diagnostic biomarkers and therapeutic targets for OS.
Main Methods:
- Literature review of existing studies on exosomal noncoding RNAs in osteosarcoma.
- Analysis of the functions of exosomal noncoding RNAs in OS tumorigenesis and development.
- Evaluation of clinical applications of exosomal noncoding RNAs as biomarkers and therapeutics.
Main Results:
- Exosomes facilitate intercellular communication within the tumor microenvironment, influencing OS progression.
- Exosomal noncoding RNAs are implicated in promoting OS cell proliferation, angiogenesis, and metastasis.
- Exosomes exhibit potential as sensitive and specific biomarkers for noninvasive OS diagnosis.
Conclusions:
- Exosomal noncoding RNAs are crucial regulators of osteosarcoma (OS) progression.
- Exosomes represent a promising avenue for developing novel noninvasive diagnostic biomarkers and therapeutic strategies for OS.
- Further research into exosomal noncoding RNAs could significantly advance OS clinical management.
More Related Videos
Related Concept Videos
02:39lncRNA - Long Non-coding RNAs
9.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.5K
01:03Rous Sarcoma Virus (RSV) and Cancer
5.9K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.9K
01:32RNA Splicing
59.8K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
59.8K
01:36Overview of Exosomes
3.3K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.3K
01:22MicroRNAs
3.5K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.5K
01:22MicroRNAs
23.5K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.5K